Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

Eli Lilly & Company (NYSE:LLY) ranks among the best low volatility stocks to buy according to analysts. On July 11, ...

Researchers analyzed nearly 60,000 public Facebook posts to identify real-world adverse events linked to GLP-1 receptor ...

Restaurants across the U.S. are introducing “Ozempic menus” with smaller, protein-rich portions to cater to millions using ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

A recent study revealed that weight loss drugs, GLP-1s, including Ozempic and Zepbound, may help in treating several chronic ...

A new analysis of 11 global studies shows that people tend to regain lost weight after stopping anti-obesity medications like ...

US lawmakers are pushing the Food and Drug Administration to control the increasing market of fake weight-loss medications.

These five upcoming data drops could usher in more effective and convenient therapies for Alzheimer’s disease and open up ...

The researchers observed “significant” weight regain at eight, 12, and 20 weeks after discontinuation. They deduced that most patients gain back the weight they initially lost for an average of 20 ...

This article delves into the approved weight loss drugs in India, their costs, and the growing market for such medications.

Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks.